Evidence map›Paper›PMID 34950601›Full record

ArticleEuropean thyroid journal2021

3D-Printed Template-Guided

Zhen Gao, Hongtao Zhang, Lijuan Zhang, Huimin Yu, Xuemin Di, Zeyang Wang, Zezhou Liu, Aixia Sui, Juan Wang, Gaofeng Shi

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European thyroid journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zhen GaoThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Hongtao ZhangThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Lijuan ZhangThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Huimin YuThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Xuemin DiThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Zeyang WangThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Zezhou LiuThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Aixia SuiThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Juan WangThe First Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Gaofeng ShiDepartment of Radiology, The 4th Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei General Hospital · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPapillary thyroid carcinoma (PTC) is typically treated with surgical resection, even in recurrent cases. However, some cases of recurrent PTC are refractory to the conventionally used locoregional radiotherapy and resection methods. CASE PRESENTATION: A 47-year-old man presented with recurrence 8 years after 2 thyroidectomy procedures for PTC and recurrent PTC. The tumor measured 6 × 7 × 8 cm

conclusionsTo the best of our knowledge, this is the first reported case of a large thyroid carcinoma that was effectively treated by 3D-printed template-guided

Indexed as

125I seed strand3D-printed templateBrachytherapyPapillary thyroid carcinomaRadiation dose

Identifiers

PMID34950601
PMCPMC8647112
OpenAlexW3212534958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.